Entyvio, Stelara plus immunomodulators not as effective for IBD Disclosures: Lutz reports no relevant disclosures. ADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . Subscribe ADDED TO EMAIL ALERTS
You ve successfully added to your alerts. You will receive an email when new content is published.
Back to Healio
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
Back to Healio
Neither Entyvio nor Stelara plus immunomodulators were as effective as other therapies for inflammatory bowel disease, according to research at Digestive Disease Week.
Sewickley native Miguel Regueiro, M.D., has been named chair of Cleveland Clinic’s Digestive Disease & Surgery Institute. “Dr. Regueiro’s leadership and focus align with our mission of caring for life, researching for health, and educating those who serve,” said Cleveland Clinic’s Chief of Staff Beri Ridgeway, M.D. “His dedication to
Dr. Miguel Regueiro has been named to the position, succeeding Dr. Matthew Walsh, who had served as interim chair since October. Walsh will continue his role as chair of the Department of General Surgery.
Microbiome Therapeutic Offers Protection Against Recurrent C diff medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.
Semaglutide Boosts Weight Loss Following Endoscopic Gastroplasty medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.